Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapyQi Xu, Jieer Ying, Xue Wu et al.|Oncogenesis|2023Cited by 24
Abstract 5336: Dissecting the molecular mechanism of trastuzumab resistance in stage IV HER2-positive gastric cancer patientsQi Xu, Jieer Ying, Haimin Weng et al.|Cancer Research|2022Cited by 0
Abstract 5132: Multi-omics analysis uncovers predictive biomarkers for the efficacy and outcomes of immune checkpoint inhibitor in combination with chemotherapy in advanced unresectable biliary tract cancersJieer Ying, Haimeng Tang, Qi Xu et al.|Cancer Research|2024Cited by 0